SMTL ID : 4xld.1

Crystal structure of the human PPARg-LBD/rosiglitazone complex obtained by dry co-crystallization and in situ diffraction

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.45 Å

Oligo State

monomer

Ligands

1 x FMT: FORMIC ACID(Non-functional Binders)

FMT.1: 0 residues within 4Å: (No contacts) No protein-ligand interaction detected (PLIP)

1 x BRL: 2,4-THIAZOLIDIINEDIONE, 5-[[4-[2-(METHYL-2-PYRIDINYLAMINO)ETHOXY]PHENYL]METHYL]-(9CL)(Non-covalent)

BRL.2: 14 residues within 4Å: Chain A: I.100, F.101, G.103, C.104, S.108, H.142, Y.146, L.149, I.160, F.182, M.183, H.268, L.288, Y.292 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:Y.146, A:L.149, A:I.160 Hydrogen bonds: A:S.108, A:Y.292, A:Y.292

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gelin, M. et al., Combining `dry' co-crystallization and in situ diffraction to facilitate ligand screening by X-ray crystallography. Acta Crystallogr.,Sect.D (2015)

Release Date

2015-08-12

Peptides

Peroxisome proliferator-activated receptor gamma: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Peroxisome proliferator-activated receptor gamma

Related Entries With Identical Sequence